Videos de Experimentos Relacionados
La pirexia y las placas persistentes: un rompecabezas desconcertante.
Anisa Mosam1, Vinesh Moodley, Pratistadevi K Ramdial
1Department of Dermatology, Nelson R Mandela School of Medicine, University of Kwazulu Natal, Congella 4013, Durban, South Africa. mosama@ukzn.ac.za
Lancet (London, England)
|August 8, 2006
Resumen
No abstract available in PubMed .
Videos de Conceptos Relacionados
También podría leer
Artículos Relacionados
Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.
Ordenar por
Same author
Impact of Atopic Dermatitis on the Quality of Life of Children in Ethiopia: A Multicenter Prospective Cohort Study.
Children (Basel, Switzerland)·2026
Same author
The development of a global health dermatologic surgery training program in Durban, South Africa.
JAAD international·2025
Same author
Cytokine biomarkers and their relationship to symptoms and quality of life in people with HIV-associated Kaposi sarcoma.
HIV medicine·2025
Same author
Prevalence of Hidradenitis Suppurativa in Durban, KwaZulu-Natal South Africa.
Dermatology (Basel, Switzerland)·2025
Same author
Physician perceptions of challenges and barriers to optimal care of systemic lupus erythematosus in Africa.
Lupus·2025
Same author
The impact of atopic dermatitis on caregivers' quality of life in Ethiopia.
Frontiers in medicine·2025
Same journal
Assisted dying and the silencing of medicine's next generation.
Lancet (London, England)·2026
Same journal
Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.
Lancet (London, England)·2026
Same journal
Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.
Lancet (London, England)·2026
Same journal
[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.
Lancet (London, England)·2026
Same journal
Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.
Lancet (London, England)·2026